The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and stabilization or ...

The consumption of sugar-sweetened beverages is driving millions of diabetes and heart disease cases worldwide, with ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

This review is adapted from Gaziano JM. Global burden of heart disease. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia ...

By bridging the gap between early detection and effective treatment, these devices could play a key role in combating the global burden of heart disease and fostering a healthier, more informed world.

According to the World Health Organization (WHO), nearly 17.9 million people die of cardiovascular diseases every year, 85% of which are heart attack and stroke. There has been a rise in heart ...

(PhilHealth) ramped up the coverage of its benefit packages for heart diseases by as much as 1,629%. PhilHealth announced the enhanced benefit packages on Thursday, January 2, as detailed in ...

As researchers continue to investigate suPAR and develop therapies to lower its levels, this breakthrough could mark a turning point in reducing the global burden of heart disease. If you care ...